KIMBERLY SILVER: Open Payments
NPI 1811084346 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,845 in 173 payments from 16 companies in 2025. Trend: 2023 $3,283 · 2024 $2,706 · 2025 $2,845
Food & beverage: $2,693Education: $151
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $828 |
| Janssen Biotech, Inc. | 22 | $381 |
| GENZYME CORPORATION | 15 | $295 |
| Regeneron Healthcare Solutions, Inc. | 11 | $238 |
| LEO Pharma Inc. | 14 | $203 |
| Galderma Laboratories, L.P. | 21 | $186 |
| UCB, Inc. | 16 | $175 |
| Arcutis Biotherapeutics, Inc. | 4 | $145 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $106 |
| Incyte Corporation | 4 | $81 |
Products named: DUPIXENT, RINVOQ, SKYRIZI, TREMFYA, ADBRY, Bimzelx, NEMLUVIO, Zoryve.
Industry payments across VA — which companies pay providers there.
